Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2016 07:00 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank and Arbutus Biopharma Announce Preclinical Collaboration in Study of Chronic Hepatitis B

HOPKINTON, Mass., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
November 18, 2016 08:58 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Announces Financing of $15 Million

HOPKINTON, Mass., Nov. 18, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
October 31, 2016 07:00 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2016 Financial Results

HOPKINTON, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
October 20, 2016 07:30 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Presents Data on STING Agonist SB 11285 at the AACR Special Conference on Tumor Immunology and Immunotherapy

HOPKINTON, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
October 13, 2016 07:30 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals to Present at Dawson James Securities 2016 Stock Growth Conference

HOPKINTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
September 06, 2016 16:05 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Abstracts on STING Agonist SB 11285 Accepted for Poster Presentations at AACR Special Conference on Tumor Immunology and Immunotherapy

HOPKINTON, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
August 22, 2016 17:00 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals, Inc. to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City on September 13th, 2016

HOPKINTON, Mass., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
August 01, 2016 17:14 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Announces Second Quarter 2016 Financial Results and Recent Highlights

HOPKINTON, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
July 28, 2016 16:05 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Appoints Dr. Todd C. Brady to its Board of Directors

MILFORD, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
June 27, 2016 08:00 ET | Source: Spring Bank Pharmaceuticals Inc.

Spring Bank Pharmaceuticals Added to Russell Microcap® Index

HOPKINTON, Mass., June 27, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...